A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection

Name: A Study to Evaluate the Pharmacokinetics, Safety, and Efficacy of Glecaprevir/Pibrentasvir in Pediatric Subjects With Genotypes 1-6 Chronic Hepatitis C Virus (HCV) Infection
Published: 2017
License: Public Domain

AbbVie · 2017

ClinicalTrials.gov · Datasets · License: Public Domain · 2017

Open Source ↗

hepatitis c virus (hcv), chronic hepatitis c virus, glecaprevir, pibrentasvir, pharmacokinetic, treatment naïve, treatment experienced, interferon (ifn), pegylated interferon (pegifn), ribavirin (rbv), sofosbuvir, non-cirrhotic cirrhosis

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 841527
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.